Mycobacterium fortuitum infection in continuous subcutaneous insulin infusion sites

Br J Dermatol. 2014 Aug;171(2):418-20. doi: 10.1111/bjd.12926. Epub 2014 Aug 6.

Authors

D López Aventín¹, B Rubio González, G Petiti Martín, S Segura, J L Rodríguez-Peralto, E Riveiro-Falkenbach, J Puig, R M Pujol

Affiliation

¹ Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. [email protected].

PMID: 24588257
DOI: 10.1111/bjd.12926

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Diabetes Mellitus, Type 1 / drug therapy
Female
Humans
Hypoglycemic Agents / administration & dosage
Infusion Pumps, Implantable / adverse effects*
Insulin Infusion Systems / adverse effects*
Insulins / administration & dosage
Mycobacterium Infections, Nontuberculous / etiology*
Mycobacterium fortuitum*

Substances

Hypoglycemic Agents
Insulins